Armata Pharmaceuticals

Associate

Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant infections using its proprietary bacteriophage-based technology. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, known as MSD outside of the United States and Canada, Armata is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent. Armata is committed to advancing phage with drug development expertise that spans bench to clinic including in-house phage specific GMP manufacturing.  




GET INVOLVED AT

WORLD ANTI-MICROBIAL RESISTANCE CONGRESS

 

To Sponsor Or Exhibit

 


Joseph Sica

joseph.sica@terrapinn.com
+1 860.508.6307

 

 

Press & Media Partnerships

 


Molly Paprota
molly.paprota@terrapinn.com
+1 646.619.1815

 

 

To Speak

 


Claire Murphy
claire.murphy@terrapinn.com
+1 646.619.1784